TD Asset Management
BMRN icon

TD Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$948K Sell
17,241
-17,881
-51% -$983K ﹤0.01% 1069
2025
Q1
$2.48M Sell
35,122
-59,008
-63% -$4.17M ﹤0.01% 910
2024
Q4
$6.19M Sell
94,130
-9,125
-9% -$600K 0.01% 754
2024
Q3
$7.29M Sell
103,255
-40,642
-28% -$2.87M 0.01% 703
2024
Q2
$11.8M Sell
143,897
-14,724
-9% -$1.21M 0.01% 597
2024
Q1
$13.9M Sell
158,621
-32,409
-17% -$2.83M 0.01% 566
2023
Q4
$18.4M Buy
191,030
+17,858
+10% +$1.72M 0.02% 496
2023
Q3
$15.3M Buy
173,172
+72,742
+72% +$6.44M 0.02% 494
2023
Q2
$8.71M Sell
100,430
-2,839
-3% -$246K 0.01% 628
2023
Q1
$10M Buy
103,269
+23,768
+30% +$2.31M 0.01% 605
2022
Q4
$8.23M Buy
79,501
+24,485
+45% +$2.53M 0.01% 636
2022
Q3
$4.68M Buy
55,016
+5,551
+11% +$472K 0.01% 774
2022
Q2
$4.1M Sell
49,465
-6,158
-11% -$510K ﹤0.01% 815
2022
Q1
$4.29M Buy
55,623
+27,485
+98% +$2.12M ﹤0.01% 860
2021
Q4
$2.49M Sell
28,138
-1,007
-3% -$89K ﹤0.01% 1081
2021
Q3
$2.25M Buy
29,145
+56
+0.2% +$4.33K ﹤0.01% 1052
2021
Q2
$2.23M Sell
29,089
-35,000
-55% -$2.69M ﹤0.01% 1065
2021
Q1
$4.84M Sell
64,089
-369
-0.6% -$27.9K 0.01% 837
2020
Q4
$5.65M Buy
64,458
+403
+0.6% +$35.3K 0.01% 757
2020
Q3
$4.87M Sell
64,055
-7,111
-10% -$541K 0.01% 712
2020
Q2
$8.78M Buy
71,166
+2,472
+4% +$305K 0.01% 541
2020
Q1
$5.81M Sell
68,694
-19,200
-22% -$1.62M 0.01% 591
2019
Q4
$7.43M Buy
87,894
+3,316
+4% +$280K 0.01% 630
2019
Q3
$5.7M Buy
84,578
+5,300
+7% +$357K 0.01% 654
2019
Q2
$6.79M Sell
79,278
-10,333
-12% -$885K 0.01% 618
2019
Q1
$7.96M Buy
89,611
+8,051
+10% +$715K 0.01% 574
2018
Q4
$6.95M Sell
81,560
-6,886
-8% -$586K 0.01% 569
2018
Q3
$8.58M Buy
88,446
+540
+0.6% +$52.4K 0.01% 578
2018
Q2
$8.28M Buy
87,906
+14,107
+19% +$1.33M 0.01% 566
2018
Q1
$5.98M Sell
73,799
-4,222
-5% -$342K 0.01% 635
2017
Q4
$6.96M Buy
78,021
+3,397
+5% +$303K 0.01% 607
2017
Q3
$6.95M Buy
74,624
+11,465
+18% +$1.07M 0.01% 591
2017
Q2
$5.74M Buy
63,159
+127
+0.2% +$11.5K 0.01% 652
2017
Q1
$5.53M Buy
63,032
+13,365
+27% +$1.17M 0.01% 661
2016
Q4
$4.11M Buy
49,667
+402
+0.8% +$33.3K 0.01% 722
2016
Q3
$4.56M Buy
49,265
+342
+0.7% +$31.6K 0.01% 723
2016
Q2
$3.81M Sell
48,923
-42,662
-47% -$3.32M 0.01% 749
2016
Q1
$7.55M Sell
91,585
-13,798
-13% -$1.14M 0.01% 557
2015
Q4
$11M Buy
105,383
+310
+0.3% +$32.5K 0.02% 464
2015
Q3
$11.1M Buy
105,073
+6,656
+7% +$701K 0.02% 436
2015
Q2
$13.5M Sell
98,417
-3,600
-4% -$492K 0.02% 439
2015
Q1
$12.7M Buy
102,017
+44,016
+76% +$5.49M 0.02% 437
2014
Q4
$5.24M Buy
58,001
+1,601
+3% +$145K 0.01% 650
2014
Q3
$4.07M Sell
56,400
-1,800
-3% -$130K 0.01% 691
2014
Q2
$3.62M Sell
58,200
-2,800
-5% -$174K 0.01% 733
2014
Q1
$4.16M Sell
61,000
-5,000
-8% -$341K 0.01% 692
2013
Q4
$4.64M Sell
66,000
-600
-0.9% -$42.2K 0.01% 646
2013
Q3
$4.81M Sell
66,600
-4,300
-6% -$311K 0.01% 612
2013
Q2
$3.96M Buy
+70,900
New +$3.96M 0.01% 639